1/62
Comprehensive vocabulary flashcards covering foundational pathophysiology concepts from Chapters 1, 2, 4, and 7, including disease framework and epidemiology, homeostasis and allostatic stress responses, mechanisms of cell injury and adaptation, and the biology of neoplasia.
Pathophysiology
The study of the functions of the human body in the disease state, based on common or "classic" presentations of disease.
Etiology
The study of causes or reasons for phenomena, identifying the causal factors that act in concert to provoke a particular disease or injury.
Idiopathic
Designates a condition or disease whose underlying cause is unknown.
Iatrogenic
Refers to a disease or adverse condition that results from an unintended or unwanted medical treatment.
Pathogenesis
The biological mechanism and developmental evolution of a disease, from the initial stimulus to the ultimate manifestation of clinical findings.
Sign
An objective, observable, or measurable manifestation of disease detected by an examiner (e.g., fever, rash, swelling, or vomiting).
Symptom
A subjective feeling of abnormality in the body experienced and reported by the patient (e.g., pain, nausea, fatigue, or headache).
Syndrome
A clinical condition where the etiology of an observed constellation of signs and symptoms has not yet been determined.
Latent Period
The interval between exposure of a tissue to an injurious agent and the first appearance of signs or symptoms; also denotes a phase during an illness when signs and symptoms temporarily abate or disappear.
Prodromal Period
The time during which the first non-specific signs or symptoms appear, indicating the onset of disease.
Exacerbation
A sudden increase in the severity of a disease or its associated signs and symptoms.
Remission
A decrease in the severity of disease signs or symptoms, which may signify cure or temporary disease subsidence.
Convalescence
The stage of recovery following an acute illness, injury, or surgical intervention.
Sequela
A subsequent pathologic condition that develops as a direct consequence of a previous illness or injury.
Epidemiology
The study of patterns of disease involving human populations, evaluating the occurrence, incidence, prevalence, transmission, and distribution across groups.
Primary Prevention
A level of prevention directed toward altering susceptibility or reducing exposure for susceptible individuals before disease occurs (e.g., vaccinations).
Secondary Prevention
A level of prevention focusing on early detection, screening, and management of disease to halt its progression.
Tertiary Prevention
A level of prevention involving rehabilitation, supportive care, physical therapy, and disability reduction to restore functioning after disease establishment.
Homeostasis
The maintenance of a relatively stable internal environment and ideal set point through negative feedback control systems despite changes in the external or internal environment.
Allostasis
The overall process of adaptive change necessary to maintain survival and well-being, altering multiple physiologic parameters to match bodily resources to environmental challenges.

General Adaptation Syndrome (GAS)
The triphasic systemic response to stress described by Hans Selye, consisting of the alarm stage, resistance/adaptation stage, and exhaustion stage.
Alarm Stage
The initial phase of the General Adaptation Syndrome involving central nervous system arousal and the fight-or-flight response, driven by the release of catecholamines (epinephrine, norepinephrine) and corticotropin-releasing hormone.
Resistance Stage
The second phase of the General Adaptation Syndrome during which the nervous and endocrine systems actively work to support allostatic restoration of homeostasis.
Exhaustion Stage
The final stage of the General Adaptation Syndrome reached when adaptive reserves are depleted and the body can no longer sustain allostatic compensation, potentially leading to death.
Allostatic Overload
The cumulative cost, wear and tear on body organs and tissues resulting from an excessive, prolonged, or ineffectively regulated allostatic stress response.

Renin-Angiotensin-Aldosterone System (RAAS)
A neurohormonal regulatory cascade wherein renal renin converts angiotensinogen to angiotensin I, converted by ACE to angiotensin II, stimulating aldosterone secretion and vasoconstriction to maintain blood pressure and fluid balance.
Psychosocial Stress
Stress originating from psychological or social situations that directly affects the central nervous system, activating stress responses even when internal sensors have detected no physiologic imbalance.
Hydropic Swelling
Reversible cellular swelling caused by intracellular water accumulation following malfunction of the ATP-dependent Na+/K+ pump, representing the initial manifestation of most reversible cell injuries.

Intracellular Accumulations
The abnormal buildup of substances inside cells caused by abnormal metabolism, defects in protein folding/transport, lack of degradation enzymes, or ingestion of indigestible materials.

Cellular Adaptation
Reversible adjustments in cell size, number, phenotype, metabolic activity, or organization in response to changes in physiologic or pathophysiologic demands.
Atrophy
A decrease in cellular size and functional capacity resulting from disuse, denervation, ischemia, nutrient deprivation, loss of endocrine signaling, or persistent injury.
Hypertrophy
An increase in individual cell mass accompanied by augmented functional capacity, driven by increased cellular protein synthesis in response to increased workload or demand.
Hyperplasia
An increase in the total number of cells in an organ or tissue resulting from accelerated mitotic division triggered by physiologic demands, hormonal stimulation, or persistent irritation.
Metaplasia
The fully reversible replacement of one adult differentiated cell type by another differentiated cell type better suited to tolerate chronic injurious stimulation.
Dysplasia
Disordered cellular growth and arrangement characterized by abnormal variations in cell size, shape, and nuclear morphology; represents a preneoplastic lesion with malignant potential.
Necrosis
Irreversible cell death resulting from severe acute injury, characterized by loss of membrane integrity, organelle breakdown, spilling of cell contents into extracellular fluid, and local inflammation.
Coagulative Necrosis
The most common form of necrosis, typical of ischemic injury in most solid organs (except the brain), characterized by protein denaturation preserving architectural outlines as relatively solid tissue.
Liquefactive Necrosis
Necrosis characterized by rapid enzymatic dissolution of dead cells by lysosomal enzymes, transforming tissue into a viscous liquid mass or abscess, typically seen in the brain.
Fat Necrosis
Enzymatic destruction of adipose tissue, commonly resulting from trauma or pancreatitis, marked by lipases releasing fatty acids that precipitate with calcium to form chalk-white areas.
Caseous Necrosis
A distinctive form of coagulative necrosis characteristic of tuberculosis lung infections, producing a crumbly, clumpy, cheese-like gross appearance.
Dry Gangrene
A form of coagulative necrosis resulting from prolonged arterial ischemia, characterized by dry, shriveled, blackened tissue demarcated from viable adjacent tissue by an obvious boundary.
Wet Gangrene
A form of liquefactive necrosis typically occurring in internal organs, appearing cold, swollen, dark, foul-smelling, and capable of rapid spread and systemic toxin release.
Gas Gangrene
A necrotic infection caused by anaerobic Clostridium bacteria, characterized by the production of gas bubbles within damaged tissues and rapid, potentially fatal tissue destruction.
Apoptosis
Regulated programmed cell death executed by an orderly intracellular suicide cascade without membrane leakage or surrounding inflammatory response.
Ischemia
The interruption of blood flow to a specific anatomical area, causing cellular hypoxia, nutrient lack, and accumulation of toxic metabolic end products like lactate.
Reperfusion Injury
Secondary cellular damage that develops after blood flow and oxygen supply are restored to previously ischemic tissues.

Programmed Senescence Theory
An aging theory positing that human cells have a predetermined replicative lifespan due to progressive telomere shortening with each successive cell division.
Neoplasia
Literally meaning "new growth," referring to an abnormal mass of proliferating cells displaying uncontrolled, autonomous growth that uncouples from normal regulatory controls.

Anaplasia
The loss of cellular differentiation and specialized functional architecture in tumor cells, marked by marked variation in size and shape (pleomorphism) and a reversion to primitive forms.
Benign Tumor
A noncancerous cellular neoplasm that grows slowly, remains encapsulated, does not invade surrounding structures or metastasize, and generally carries a favorable prognosis.
Malignant Neoplasm
Cancer; an aggressive tumor characterized by rapid growth, anaplasia, local invasion through basement membranes, and potential to metastasize to distant sites.
Carcinoma
A malignant neoplasm arising from transformed epithelial cells, which accounts for approximately 90% of all human cancers.
Proto-oncogene
A normal cellular gene encoding proteins that promote physiologic cell division and survival, such as growth factors, receptors, signaling kinases, and transcription factors.
Oncogene
A mutated, overactive, or overexpressed form of a proto-oncogene that autonomously drives excessive cell proliferation independent of normal regulatory signals.
Tumor Suppressor Gene
A gene that normally acts as a cellular checkpoint to inhibit excessive cell proliferation, facilitate DNA repair, or trigger apoptosis in damaged cells.
p53 Gene
A critical tumor suppressor gene coding for a nuclear transcription factor that arrests the cell cycle at G1/S for DNA repair or triggers apoptosis; mutated in approximately 50% of human cancers.
Carcinogenesis Initiation
The initial step of carcinogenesis involving an irreversible genetic mutation or permanent DNA sequence damage in a single cell.
Carcinogenesis Promotion
The second stage of carcinogenesis wherein initiated cells are stimulated to divide and clonal expansion occurs under the influence of growth promoters.
Carcinogenesis Progression
The final stage of carcinogenesis in which proliferating neoplastic cells undergo further phenotypic changes, acquiring malignant properties, invasiveness, and genomic instability.

Metastasis
The process whereby malignant tumor cells detach from the primary tumor, invade extracellular matrix, intravasate into vascular or lymphatic channels, and establish secondary colonies at distant sites.
Angiogenesis
The generation of new capillary blood vessels from preexisting vasculature, initiated by tumor-secreted factors to support neoplastic growth and provide metastatic access.
Tumor Grading
The microscopic histologic assessment of tumor cells to evaluate the degree of anaplasia and cellular differentiation (differentiated versus undifferentiated).
Tumor Staging
The clinical determination of the anatomical location, primary tumor size, and extent of regional and distant disease spread in the host.